DFDV JP is Japan’s first Solana-based treasury for institutional investors. Solana’s price rose 3.56% following the launch of DFDV JP in Japan. DFDV now holds over 2 million SOL, valued at $427 million. Japan’s forward-looking regulatory environment supports blockchain adoption. DeFi Development Corp. (DFDV) has partnered with Superteam Japan to launch the first Solana-based digital [...] The post DFDV Partners with Superteam Japan to Launch Solana Treasury for Institutions appeared first on CoinCentral.DFDV JP is Japan’s first Solana-based treasury for institutional investors. Solana’s price rose 3.56% following the launch of DFDV JP in Japan. DFDV now holds over 2 million SOL, valued at $427 million. Japan’s forward-looking regulatory environment supports blockchain adoption. DeFi Development Corp. (DFDV) has partnered with Superteam Japan to launch the first Solana-based digital [...] The post DFDV Partners with Superteam Japan to Launch Solana Treasury for Institutions appeared first on CoinCentral.

DFDV Partners with Superteam Japan to Launch Solana Treasury for Institutions

2025/10/09 18:45
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
  • DFDV JP is Japan’s first Solana-based treasury for institutional investors.
  • Solana’s price rose 3.56% following the launch of DFDV JP in Japan.
  • DFDV now holds over 2 million SOL, valued at $427 million.
  • Japan’s forward-looking regulatory environment supports blockchain adoption.

DeFi Development Corp. (DFDV) has partnered with Superteam Japan to launch the first Solana-based digital asset treasury in Japan. This new initiative, DFDV JP, aims to provide Japanese institutions with an accessible platform for participating in Solana’s staking, validator network, and decentralized finance (DeFi) ecosystem. The news comes as institutional interest in Solana grows, with market reactions already showing positive signs for the token’s price.

DFDV and Superteam Japan’s Strategic Partnership

DeFi Development Corp. has teamed up with Superteam Japan to introduce a new platform designed to attract institutional interest in Solana. The launch of DFDV JP marks the first Solana-based digital asset treasury in Japan.

This follows DeFi Development’s earlier expansion into South Korea with the launch of DFDV KR in 2025. The initiative leverages Superteam Japan’s established presence in the region, including its partnerships with entities like Minna Bank and Fireblocks.

Parker White, COO and CIO of DFDV, noted that Japan’s forward-thinking regulatory environment and established financial infrastructure make it an ideal market for this expansion.

He mentioned that this partnership aims to provide Japanese institutions with a clear path to engage with Solana’s ecosystem, especially through staking and validator participation. The project’s launch reflects a broader strategy to deepen institutional adoption of Solana on a global scale.

Japan’s Growing Blockchain Presence

Japan’s regulatory environment has long been seen as conducive to blockchain and digital asset adoption. With the launch of DFDV JP, Japanese institutions now have an easier way to access Solana’s growing ecosystem. The Solana blockchain has gained recognition for its high-speed transactions and lower fees compared to other networks, positioning it as a viable option for institutional investors.

Hisashi Oki, Country Lead of Superteam Japan, called the collaboration a “defining milestone” for the country’s blockchain sector. He added that this partnership is critical for creating an accessible bridge for Japanese investors to participate in Solana’s growth. The venture also aligns with Superteam Japan’s efforts to foster enterprise adoption, including stablecoin projects with local financial institutions.

The Impact on Solana’s Price

The announcement of DFDV JP has also influenced the price of Solana. As of October 2025, Solana’s price has seen a modest increase of 3.56%, rising to $227.40. This is part of a larger trend where Solana has managed to outperform broader market movements in recent days. 

Analysts believe that the timing of DFDV JP’s launch aligns with growing anticipation for the potential approval of Solana ETFs by the U.S. Securities and Exchange Commission (SEC). This event could further fuel institutional demand for Solana.

In the meantime, DeFi Development Corp. has been building its position in the Solana market. As of the latest report, DFDV holds approximately 2.027 million SOL, valued at $427 million. This strategic accumulation reflects the company’s commitment to both capital appreciation and active participation in the Solana network.

Broader Market Trends and Institutional Adoption

DFDV’s partnership with Superteam Japan underscores the growing global trend of institutional adoption of blockchain and cryptocurrency. The digital asset treasury model has been successfully tested in markets like South Korea, and it now looks poised to gain traction in Japan. The move mirrors broader corporate trends, where companies like MicroStrategy and Tesla have added digital assets to their balance sheets.

Japan’s mature financial infrastructure and clear regulatory guidelines make it an attractive market for digital assets. The establishment of DFDV JP offers institutions in Japan the opportunity to diversify their portfolios with Solana-based assets, providing a new avenue for growth within the country’s rapidly evolving crypto landscape.

The post DFDV Partners with Superteam Japan to Launch Solana Treasury for Institutions appeared first on CoinCentral.

Market Opportunity
Oasis Logo
Oasis Price(ROSE)
$0.01161
$0.01161$0.01161
-0.08%
USD
Oasis (ROSE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09